TFPM Q1 2026 Earnings EPS Surpasses Estimates as Royalty Performance Drives Results WNC Q1 2026 Earnings EPS Falls Sharply Below Expectations as Operational Headwinds Persist OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns IMO Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 1955 Below Consensus